◆ ACS medicinal chemistry letters2026-08-13· Drug discovery
Novel Compounds as SARS-CoV-2-Related 3C-Like Protease Inhibitors for Treating Coronavirus Infections.
Ram W Sabnis
原始摘要（英文原文）· Original abstract
Provided herein are novel compounds as SARS-CoV-2-related 3C-like protease (3CLPRO) inhibitors, pharmaceutical compositions, use of such compounds in treating coronavirus infections, and processes for preparing such compounds.